NASDAQ:GILD
Gilead Sciences, Inc.
- Stock
industry
Drug Manufacturers / Generalexchange
NASDAQ Global Selectwebsite
www.gilead.comipo date
Jan 01, 1992full time employees
17,000currency
USD
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla pro...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus
investors
Partners | Funding Round | Investor Name | Lead Investor |
---|---|---|---|
— | Post-IPO Equity - Gilead Sciences | Abingworth | Yes |
— | Seed Round - Gilead Sciences | Venrock | — |
investments
Money Raised | Funding Round | Lead Investor | Announced Date | Organization Name |
---|---|---|---|---|
$320M | Post-IPO Equity - Arcus Biosciences | Yes | 29-01-2024 | Arcus Biosciences |
A$21.3M | Post-IPO Equity - Hookipa Pharma | Yes | 21-12-2023 | Hookipa Pharma |
$15.2M | Post-IPO Equity - Assembly Biosciences | Yes | 17-10-2023 | Assembly Biosciences |
$35M | Series B - Tentarix Biotherapeutics | — | 06-09-2023 | Tentarix Biotherapeutics |
— | Corporate Round - Tentarix Biotherapeutics | Yes | 15-08-2023 | Tentarix Biotherapeutics |
$60M | Series B - Kyverna Therapeutics | — | 03-08-2023 | Kyverna Therapeutics |
$8M | Grant - CDA Foundation | Yes | 20-07-2023 | CDA Foundation |
— | Grant - Power Safe Place Resource Center of Virginia | Yes | 22-03-2023 | Power Safe Place Resource Center of Virginia |
— | Grant - My Brother's Keeper | Yes | 22-03-2023 | My Brother's Keeper |
— | Grant - Central Illinois Friends | Yes | 22-03-2023 | Central Illinois Friends |
acquisitions
Price | Acquiree Name | Announced Date | Transaction Name |
---|---|---|---|
— | XinThera | 09-05-2023 | XinThera acquired by Gilead Sciences |
$405M | MiroBio | 04-08-2022 | MiroBio acquired by Gilead Sciences |
€1.5B | MYR GmbH | 10-12-2020 | MYR GmbH acquired by Gilead Sciences |
$21B | Immunomedics | 13-09-2020 | Immunomedics acquired by Gilead Sciences |
$4.9B | Forty Seven | 02-03-2020 | Forty Seven acquired by Gilead Sciences |
$567M | Cell Design Labs | 07-12-2017 | Cell Design Labs acquired by Gilead Sciences |
$11.9B | Kite Pharma | 28-08-2017 | Kite Pharma acquired by Gilead Sciences |
— | Nimbus Apollo | 04-04-2016 | Nimbus Apollo acquired by Gilead Sciences |
$65M | Epitherapeutics | 06-05-2015 | Epitherapeutics acquired by Gilead Sciences |
$470M | Phenex Pharmaceuticals | 06-01-2015 | Phenex Pharmaceuticals acquired by Gilead Sciences |
recent investments
Money Raised | Funding Round | Lead Investor | Announced Date | Organization Name |
---|---|---|---|---|
$320M | Post-IPO Equity - Arcus Biosciences | Yes | 29-01-2024 | Arcus Biosciences |
A$21.3M | Post-IPO Equity - Hookipa Pharma | Yes | 21-12-2023 | Hookipa Pharma |
$15.2M | Post-IPO Equity - Assembly Biosciences | Yes | 17-10-2023 | Assembly Biosciences |
$35M | Series B - Tentarix Biotherapeutics | — | 06-09-2023 | Tentarix Biotherapeutics |
— | Corporate Round - Tentarix Biotherapeutics | Yes | 15-08-2023 | Tentarix Biotherapeutics |
$60M | Series B - Kyverna Therapeutics | — | 03-08-2023 | Kyverna Therapeutics |
$8M | Grant - CDA Foundation | Yes | 20-07-2023 | CDA Foundation |
— | Grant - Power Safe Place Resource Center of Virginia | Yes | 22-03-2023 | Power Safe Place Resource Center of Virginia |
— | Grant - My Brother's Keeper | Yes | 22-03-2023 | My Brother's Keeper |
— | Grant - Central Illinois Friends | Yes | 22-03-2023 | Central Illinois Friends |